This inventor holds 2 USPTO granted patents. Top assignee: Kiniksa Pharmaceuticals, Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovations of Phillip M. Levesque
Introduction
Phillip M. Levesque is a notable inventor based in Wellesley, MA, who has made significant contributions to the field of biotechnology. With a focus on developing stable formulations for therapeutic antibodies, he has been instrumental in advancing medical treatments.
Latest Patents
Phillip M. Levesque holds two patents, both centered around stable anti-oncostatin M receptor (OSMR) antibody formulations. His latest invention provides stable formulations comprising an anti-OSMR antibody with a pH ranging from approximately 6.0 to 7.6. Importantly, these formulations ensure that less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species, enhancing the stability and efficacy of the treatment.
Career Highlights
Levesque is currently associated with Kiniksa Pharmaceuticals, Ltd., where he continues to innovate in the field of antibody formulations. His work is crucial in the development of therapies that target specific receptors, which can lead to improved patient outcomes.
Collaborations
He collaborates with talented professionals such as Mark Cornell Manning and Zahra Shahrokh, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Phillip M. Levesque's contributions to the field of biotechnology through his patents and collaborations highlight his role as a key inventor in the development of stable antibody formulations. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile